Pilkiewicz Carolyn 13D and 13G filings for Kintara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-07 1:26 pm Sale |
2021-12-31 | 13G | Kintara Therapeutics, Inc. KTRA |
Pilkiewicz Carolyn | 669 2.410% |
-321 (-32.46%) |
Filing |
| 2021-02-08 3:18 pm Sale |
2020-12-31 | 13G | Kintara Therapeutics, Inc. KTRA |
Pilkiewicz Carolyn | 990 7.030% |
-300 (-23.25%) |
Filing |
| 2020-11-16 2:37 pm Purchase |
2020-08-19 | 13G | Kintara Therapeutics, Inc. KTRA |
Pilkiewicz Carolyn | 1,290 9.150% |
1,290 (New Position) |
Filing |